Cita APA

Muth, S. T., Saung, M. T., Blair, A. B., Henderson, M. G., Thomas, D. L., & Zheng, L. (2020). CD137 Agonist-based Combination Immunotherapy Enhances Activated, Effector Memory T cells and Prolongs Survival in Pancreatic Adenocarcinoma. Cancer Lett.

Chicago Style Citation

Muth, Stephen T., May Tun Saung, Alex B. Blair, MacKenzie G. Henderson, Dwayne L. Thomas, i Lei Zheng. "CD137 Agonist-based Combination Immunotherapy Enhances Activated, Effector Memory T Cells and Prolongs Survival in Pancreatic Adenocarcinoma." Cancer Lett 2020.

Cita MLA

Muth, Stephen T., et al. "CD137 Agonist-based Combination Immunotherapy Enhances Activated, Effector Memory T Cells and Prolongs Survival in Pancreatic Adenocarcinoma." Cancer Lett 2020.